Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 7 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 25,778 followers.

#Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, #clinicaltrials, and future directions 👨‍⚕️👩‍⚕️ Hirokazu Takami & Koichi Ichimura Read here 👉 https://t.co/d2DhmVaMI7

16 Sep 2022

Reply Repost Favourite

Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions: CNS germ cell tumors (GCTs) preferentially occur in pediatric and adolescent… #oncology https://t.co/YJ

05 Sep 2022

Reply Repost Favourite

New research: Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions: CNS germ cell tumors (GCTs) preferentially occur in pediatric and adolescent… https://t.c

05 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.